Mohammed Alshalalfa

microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients

Reda Alhajj, Tarek A. Bismar, Ashraf Bakkar, 2016, Molecular Biology Reports.

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

Menggang Yu, Arul M. Chinnaiyan, Felix Y. Feng, 2017, JAMA oncology.

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Robert J. Gillies, Radka Stoyanova, Elai Davicioni, 2016, Oncotarget.

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications

Dong Lin, Cenk Sahinalp, Harrison Tsai, 2018, GigaScience.

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Adam P Dicker, Menggang Yu, Hussam Al-Deen Ashab, 2016, The Lancet. Oncology.